BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/1/2016 9:28:00 AM | Browse: 620 | Download: 713
Publication Name World Journal of Gastroenterology
Manuscript ID 20143
Country of Manuscript Source Italy
2015-05-29 10:00
Peer-Review Started
2015-06-01 09:55
To Make the First Decision
2015-10-14 17:02
Return for Revision
2015-10-15 14:04
2015-12-05 19:35
Second Decision
2015-12-18 16:04
Accepted by Journal Editor-in-Chief
2015-12-18 17:01
Accepted by Company Editor-in-Chief
2015-12-30 17:41
Articles in Press
2015-12-30 17:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-01-23 11:36
Publish the Manuscript Online
2016-01-31 11:48
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript type Topic Highlights
Article Title Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Manuscript Source Invited Manuscript
All Author List Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci and Stefano Fiorucci
Funding Agency and Grant Number
Correspondence To Eleonora Distrutti, MD, S.C. di Gastroenterologia ed Epatologia, Azienda Ospedaliera di Perugia, 06100 Perugia, Italy. eleonoradistrutti@katamail.com
Keywords Irritable bowel syndrome; Gut microbiota; Probiotics; Prebiotics; Synbiotics; Antibiotics; Fecal transplantation
Core Tip In the last decade, the gut microbiota has provided support to the concept that a disturbed intestinal ecology could promote development and maintenance of symptoms in irritable bowel syndrome (IBS). As a correlate, manipulation of gut microbiota represents a new strategy for the treatment of this multifactorial disease. Probiotics appear an attractive option in terms of both efficacy and safety, while prebiotics, synbiotics and antibiotics still need for-mation. Fecal transplant has recently gained a new life as therapeutic option for those patients with an altered gut ecosystem, but data on IBS are scanty and randomized, placebo-controlled studies are required.
Publish Date 2016-01-31 11:48
Citation Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241
Url http://www.wjgnet.com/1007-9327/full/v22/i7/2219.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i7.2219
Full Article (PDF) WJG-22-2219.pdf
Full Article (Word) WJG-22-2219.doc
Manuscript File 20143-Review.docx
Answering Reviewers 20143-Answering reivew(s).pdf
Audio Core Tip 20143-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 20143-Conflict-of-interest statement.pdf
Copyright License Agreement 20143-Copyright assignment.pdf
Peer-review Report 20143-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 20143-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 20143-Scientific misconduct check.pdf
Scientific Editor Work List 20143-Scientific editor work list.pdf